Research priorities in pharmacokinetics

Por Tucker, Geoffrey T
Publicado em 2012

Personalized Drug Dosage – Closing the Loop

Por Tucker, Geoffrey T
Publicado no Pharm Res (2016)

SYMBOLS IN PHARMACOKINETICS

Por Rowland, Malcolm, Tucker, Geoffrey
Publicado em 1982

Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Por Neuhoff, Sibylle, Tucker, Geoffrey T.
Publicado no Br J Clin Pharmacol (2018)

What's in a name?

Por Tucker, Geoffrey T, Miners, John O
Publicado em 2011

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential—towards a consensus

Por Tucker, Geoffrey T, Houston, J Brian, Huang, Shiew-Mei
Publicado em 2001

The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example

Por Dickinson, Gemma L, Lennard, Martin S, Tucker, Geoffrey T, Rostami-Hodjegan, Amin
Publicado em 2007

The Effect of Ethanol on the Release of Opioids from Oral Prolonged-Release Preparations

Por Walden, Malcolm, Nicholls, Fiona A., Smith, Kevin J., Tucker, Geoffrey T.
Publicado em 2007

Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis

Por Johnson, Trevor N, Tanner, M Stuart, Taylor, Christopher J, Tucker, Geoffrey T
Publicado em 2001

Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes

Por Rostami-Hodjegan, Amin, Wolff, Kim, Hay, Alastair W M, Raistrick, Duncan, Calvert, Robert, Tucker, Geoffrey T
Publicado em 1999

Population-Based Mechanistic Prediction of Oral Drug Absorption

Por Jamei, Masoud, Turner, David, Yang, Jiansong, Neuhoff, Sibylle, Polak, Sebastian, Rostami-Hodjegan, Amin, Tucker, Geoffrey
Publicado em 2009

The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)

Por Shah, Vinod P., Besancon, Luc J. R., Stolk, Pieter, Tucker, Geoffrey, Crommelin, Daan J. A.
Publicado em 2010

Assessment of algorithms for predicting drug–drug interactions via inhibition mechanisms: comparison of dynamic and static models

Por Guest, Eleanor J, Rowland-Yeo, Karen, Rostami-Hodjegan, Amin, Tucker, Geoffrey T, Houston, J Brian, Galetin, Aleksandra
Publicado em 2011

Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment

Por Shiran, Mohammad-Reza, Lennard, Martin S, Iqbal, Mohammad-Zafar, Lagundoye, Oldwale, Seivewright, Nicholas, Tucker, Geoffrey T, Rostami-Hodjegan, Amin
Publicado em 2009

Does age affect gastric emptying time? A model‐based meta‐analysis of data from premature neonates through to adults

Por Bonner, Jennifer J., Vajjah, Pavan, Abduljalil, Khaled, Jamei, Masoud, Rostami‐Hodjegan, Amin, Tucker, Geoffrey T., Johnson, Trevor N.
Publicado no Biopharm Drug Dispos (2015)

An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria

Por Matthews, Angela, Johnson, Trevor N, Rostami-Hodjegan, Amin, Chakrapani, Anupam, Wraith, J Edward, Moat, Stuart J, Bonham, James R, Tucker, Geoffrey T
Publicado em 2002

Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation

Por Polasek, Thomas M., Tucker, Geoffrey T., Sorich, Michael J., Wiese, Michael D., Mohan, Titus, Rostami‐Hodjegan, Amin, Korprasertthaworn, Porntipa, Perera, Vidya, Rowland, Andrew
Publicado no Br J Clin Pharmacol (2018)